Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Biotechnology
Biotechnology
Health
23andMe users are being urged to delete their data. Here’s how to do it
By
Alexa Mikhail
and
Beth Greenfield
March 24, 2025
Commentary
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By
Senior Editor
March 10, 2025
Leadership
A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By
Market Analyst
March 1, 2025
Health
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By
Trading Desk
January 16, 2025
Aging Well
Arnold Schwarzenegger is joining a Coins2Day 500 company to solve a great problem of his generation
By
Staff Writer
November 13, 2024
Health
How to delete your DNA data from 23andMe
By
Financial Writer
October 5, 2024
Tech
Meta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream
By
Industry Analyst
June 25, 2024
Commentary
I’ve been practicing medicine at a renowned institution for 40 years. Society isn’t ready for us to reverse the aging process across an entire population
By
Tech Reporter
June 20, 2024
Life
A 45-year-old tech CEO is spending millions a year to be 18 again—even though his doctor admits the results are minimal
By
Editorial Team
January 26, 2023
Finance
Biden’s new executive order triggers new front in U.S.-China economic competition
By
Digital Assets Editor
September 12, 2022
Newsletters
At financial software giant Intuit, A.I. is becoming ‘foundational’ to how the company operates
By
News Correspondent
August 26, 2022
Newsletters
A.I. is rapidly transforming biological research—with big implications for everything from drug discovery to agriculture to sustainability
By
Market Analyst
July 28, 2022
Magazine
Moderna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?
By
Contributing Writer
December 2, 2021
Newsletters
What’s big in A.I. this year
By
Editorial Team
October 12, 2021
Tech
DeepMind unveils how it solved a 50-year-old scientific challenge that could speed drug discovery
By
Contributing Writer
July 15, 2021
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Contributing Writer
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Staff Writer
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Blockchain Reporter